NOUV Financials 07/15/2014 19:05:12
Nouveau Life Pharmaceuticals, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue - 7
Cost of Revenue - -
Gross Profit - 7
Operating Expenses
Research and Development - -
Sales, General and Admin. - 6
Non-Recurring Items - -
Other - -
Operating Income - 1
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax - 1
Interest Expense - -
Earnings Before Tax - 1
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations - 1
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income - 1
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders - 1
Nouveau Life Pharmaceuticals, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue - 7
Cost of Revenue - -
Gross Profit - 7
Operating Expenses
Research and Development - -
Sales, General and Admin. - 6
Non-Recurring Items - -
Other - -
Operating Income - 1
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax - 1
Interest Expense - -
Earnings Before Tax - 1
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations - 1
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income - 1
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders - 1
